Elizabeth Holmes: It came from believing that it’s possible to realize a world in which early detection is the norm, and a world in which you’re not finding out once someone already has a symptom that makes it so late in the disease progression process that you can’t really intervene effectively — to one in which people are intervening at the time it matters.  And if you spend a lot of time thinking about that, you learn that laboratory information and blood diagnostics — blood and urine and feces and these other matrices — drive 70 to 80 percent of clinical decisions.  If we could make that information more accessible at the time it mattered — which is our mission, access to actionable information at the time it matters — we could begin to help create a world in which early detection becomes the norm.  So we’ve spent the last 11 years transforming people’s access to actionable health information.